|
Sign In to gain access to subscriptions and/or personal tools.
|
Histopathologic Approaches to Detect Changes Indicative of Immunotoxicity
C. Frieke Kuper
TNO Toxicology Division, 3700 AJ Zeist, The Netherlands
Johannes H. Harleman
Novartis Pharma AG, CH 4002 Basel, Switzerland
Hans B. Richter-Reichelm
Federal Institute for Health Protection of Consumers and Veterinary Medicine, D-14196 Berlin, Germany
Joseph G. Vos
National Institute of Public Health and the Environment, 3720 BA Bilthoven, The Netherlands, Faculty of Veterinary Medicine, 3508 TD Utrecht, The Netherlands
Toxicologic pathology is crucial in the identification and characterization of health effects following exposure to xenobiotics, mainly in toxicity experiments in rodents. Regarding regulatory toxicology, histopathology of lymphoid organs and tissues is a cornerstone in the identification of immunotoxic compounds. A 2-tier testing system is usually employed in which the first tier is a general screen for (immuno)toxicity and the second tier consists of specific immune function studies, including host resistance tests or mechanistic studies. The role attributed to histopathology of lymphoid organs in the updated Organisation for Economic Cooperation and Development and Food and Drug Administration guidelines requires improvement and standardization of the histopathology procedures. Optimalization and standardization was started in an international collaborative immunotoxicity study (ICICIS). However, several problems were left unaddressed, mostly because of the few compounds tested in this study. Based on the results of the ICICIS study and the morphologic changes induced by immunotoxic/immunomodulatory compounds observed in other investigations, suggestions are given to further improve the identification and (semi)quantification of histopathologic changes in lymphoid organs and tissues.
Key Words: Lymphoid organs • thymus • spleen • lymph node • mucosa-associated lymphoid tissue (MALT) • morphology • immunosuppression • immunomodulation
Toxicologic Pathology, Vol. 28, No. 3,
454-466 (2000)
DOI: 10.1177/019262330002800317
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
G. Pearse, A. Pietersma, J. Cunliffe, J. R. Foster, J. Turton, N. Derbyshire, and K. J. Randall
Time-course Study of the Immunotoxic Effects of the Anticancer Drug Chlorambucil in the Rat
Toxicol Pathol,
December 1, 2009;
37(7):
887 - 901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J. Randall and G. Pearse
A Dual-label Technique for the Immunohistochemical Demonstration of T-Lymphocyte Subsets in Formalin-fixed, Paraffin-Embedded Rat Lymphoid Tissue
Toxicol Pathol,
October 1, 2008;
36(6):
795 - 804.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Spoor, Z. A. Radi, and R. W. Dunstan
Characterization of Age- and Gender-related Changes in the Spleen and Thymus from Control Cynomolgus Macaques Used in Toxicity Studies
Toxicol Pathol,
July 1, 2008;
36(5):
695 - 704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Burns-Naas, K. L. Hastings, G. S. Ladics, S. L. Makris, G. A. Parker, and M. P. Holsapple
What's So Special about the Developing Immune System?
International Journal of Toxicology,
March 1, 2008;
27(2):
223 - 254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Missima and J. M. Sforcin
Green Brazilian Propolis Action on Macrophages and Lymphoid Organs of Chronically Stressed Mice
Evid. Based Complement. Altern. Med.,
March 1, 2008;
5(1):
71 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Kuper, M. Van Zijverden, C. Klaassen, M. Tegelenbosch-Schouten, and A. P.M. Wolterbeek
Effects of Cyclosporin A and Cyclophosphamide on Peyer's Patches in Rat, Exposed in utero and Neonatally or During Adult Age
Toxicol Pathol,
February 1, 2007;
35(2):
226 - 232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. R. Maronpot
Enhanced Histopathology of Lymphoid Tissues
Toxicol Pathol,
August 1, 2006;
34(5):
631 - 633.
[Full Text]
[PDF]
|
|
|
|
|
|
|
STP Immunotoxicology Working Group, P. Haley, R. Perry, D. Ennulat, S. Frame, C. Johnson, J-M Lapointe, A. Nyska, P. W. Snyder, D. Walker, et al.
STP Position Paper: Best Practice Guideline for the Routine Pathology Evaluation of the Immune System
Toxicol Pathol,
April 1, 2005;
33(3):
404 - 407.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Germolec, M. Kashon, A. Nyska, C. F. Kuper, C. Portier, C. Kommineni, K. A. Johnson, and M. I. Luster
The Accuracy of Extended Histopathology to Detect Immunotoxic Chemicals
Toxicol. Sci.,
December 1, 2004;
82(2):
504 - 514.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Dean
A Brief History of Immunotoxicology and a Review of the Pharmaceutical Guidelines
International Journal of Toxicology,
March 1, 2004;
23(2):
83 - 90.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Germolec, A. Nyska, M. Kashon, C. F. Kuper, C. Portier, C. Kommineni, K. A. Johnson, and M. I. Luster
Extended Histopathology in Immunotoxicity Testing: Interlaboratory Validation Studies
Toxicol. Sci.,
March 1, 2004;
78(1):
107 - 115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. L. Bunn, P. J. Parsons, E. Kao, and R. R. Dietert
Exposure to Lead during Critical Windows of Embryonic Development: Differential Immunotoxic Outcome Based on Stage of Exposure and Gender
Toxicol. Sci.,
November 1, 2001;
64(1):
57 - 66.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. de Waard, J. Garssen, J. Snel, G. C. A. M. Bokken, T. Sako, J. H. J. Huis in 't Veld, and J. G. Vos
Enhanced Antigen-Specific Delayed-Type Hypersensitivity and Immunoglobulin G2b Responses after Oral Administration of Viable Lactobacillus casei YIT9029 in Wistar and Brown Norway Rats
Clin. Vaccine Immunol.,
July 1, 2001;
8(4):
762 - 767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Tryphonas and C. Gopinath
A Synopsis of the Third International Federation of Societies of Toxicologic Pathologists Conference
Toxicol Pathol,
May 1, 2000;
28(3):
370 - 374.
[PDF]
|
|
|
|
|
